Both in Pharmaceuticals
Canopy Growth vs Emergent Biosolutions
Over the past year CGC returned −50.9% and EBS returned −34.4%; their daily moves had a correlation of 0.10.
CGC −50.9% EBS −34.4%Growth of $1, one year, split-adjusted
| Metric | CGC | EBS |
|---|---|---|
| Price | $0.6720 | $6.20 |
| Market cap | $284.3M | $317.9M |
| Today | −6.67% | −1.43% |
| 1 month | −30.5% | −8.3% |
| 6 months | −51.3% | −25.2% |
| Year to date | −41.1% | −49.8% |
| 1 year | −51.7% | −36.9% |
| Revenue growth (YoY) | +7.8% | +66.3% |
| Gross margin | 27.4% | 58.6% |
| Net margin | −18.0% | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 0.4× |
| Net cash | $67.9M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 96.7% |
| Short % of float | 6.4% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).